Kinetics Mutual Funds, Inc. The Medical Fund (USD) Kinetics Mutual Funds, Inc. The Medical Fund operates as a non-diversified investment vehicle, allocating all of its capital exclusively to the Medical Portfolio, a specific series within the Kinetics Portfolios Trust. The Medical Portfolio is strategically mandated to invest a minimum of 80% of its net assets—inclusive of any funds borrowed for investment purposes—into a range of equity and equity-linked securities. These include common shares, convertible debt instruments, warrants, and other securities sharing characteristics with common stock. The target companies, both domestic and international, are primarily engaged across medical research, pharmaceutical, and medical technology sectors, as well as associated technology industries. A significant emphasis is placed on entities dedicated to cancer research and the development of new drugs.

Kinetics Mutual Funds, Inc. The Medical Fund (USD) Passive

470 Park Avenue South, New York, NY,

Stock Price USD

Price Change

Last Dividend USD

MEDRX's stock peer is CUHAX (Victory US 500 Enhanced Volatility Wtd Index Fund)

MEDRX's stock peer is CUHCX (Victory US 500 Enhanced Volatility Wtd Index Fund)

MEDRX's stock peer is FIRUX (Fidelity Simplicity RMD 2015 Fund)

MEDRX's stock peer is GEDTX (GMO Emerging Domestic Opportunities Fund)

MEDRX's stock peer is HEMAX (Janus Henderson Emerging Markets Fund)

MEDRX's stock peer is HEMCX (Janus Henderson Emerging Markets Fund)

MEDRX's stock peer is HEMIX (Janus Henderson Emerging Markets Fund)

MEDRX's stock peer is HEMSX (Janus Henderson Emerging Markets Fund)

MEDRX's stock peer is NSFLX (Natixis Sustainable Future 2055 Fund)

MEDRX's stock peer is XDSCX (Cross Shore Discovery Fund)

Financial Services Asset Management

Kinetics Mutual Funds, Inc. The Medical Fund operates as a non-diversified investment vehicle, allocating all of its capital exclusively to the Medical Portfolio, a specific series within the Kinetics Portfolios Trust. The Medical Portfolio is strategically mandated to invest a minimum of 80% of its net assets—inclusive of any funds borrowed for investment purposes—into a range of equity and equity-linked securities. These include common shares, convertible debt instruments, warrants, and other securities sharing characteristics with common stock. The target companies, both domestic and international, are primarily engaged across medical research, pharmaceutical, and medical technology sectors, as well as associated technology industries. A significant emphasis is placed on entities dedicated to cancer research and the development of new drugs.

Dividend Stats Yield is calculated via trailing-12-month period

Dividend	Yield	Dividend Frequency
0.26	0.84 %	Annual
0.31	1.10 %	Annual
0.35	1.33 %	Annual
0.29	1.23 %	Annual
0.26	1.11 %	Annual
0.22	0.94 %	Annual
0.12	0.53 %	Annual
0.05	0.20 %	Annual
0.06	0.26 %	Annual
0.36	1.56 %	Annual
0.25	1.07 %	Annual
0.11	0.54 %	Special
0.02	0.76 %	Quarterly
0.18	0.68 %	Annual
0.16	0.69 %	Annual
0.10	0.42 %	Annual
0.04	0.15 %	Annual
0.08	0.33 %	Annual
0.03	0.13 %	Annual

Disclaimers

StockQuay.com is not operated by a broker, dealer, or registered investment advisor. Under no circumstances should any information published on StockQuay.com be considered a recommendation to buy, sell, or hold any security. The content on this site and in its associated newsletters is intended solely for informational and educational purposes and does not constitute investment advice or financial recommendations.

Individuals or entities featured or referenced on StockQuay.com may engage in trading activity involving the securities mentioned in any article or report before or after such content is published. These individuals or entities are not affiliated with StockQuay.com, and their inclusion does not imply endorsement or accuracy of their views or actions.

StockQuay.com, its owners, or its affiliates shall not be held liable to any user or third party for any damages or losses arising from the use of content on this website. This includes, but is not limited to, investment losses, loss of profit, loss of data, missed opportunities, or indirect, incidental, or consequential damages.

Data is updated daily and is not guaranteed to be accurate or complete.

Past performance is not indicative of future results. Please conduct your own research or consult with a qualified financial advisor before making any investment decisions